Anika Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Anika Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Anika Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$28M, a 265% decline year-over-year.
  • Anika Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$96.7M, a 217% decline year-over-year.
  • Anika Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$87.6M, a 352% decline from 2022.
  • Anika Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$19.4M, a 842% decline from 2021.
  • Anika Therapeutics, Inc. annual Operating Income (Loss) for 2021 was $2.62M.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$96.7M -$28M -$20.3M -265% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 -$76.4M $161K +$3.79M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$80.1M -$5.06M +$7.49M +59.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$87.6M -$63.8M -$57.1M -857% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 -$30.5M -$7.67M -$1.88M -32.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 -$28.6M -$3.63M -$250K -7.39% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$28.4M -$12.6M -$9M -253% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$19.4M -$6.67M +$2.46M +26.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 -$21.9M -$5.8M -$7.1M -546% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$14.8M -$3.38M -$12.6M -137% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$2.2M -$3.55M -$4.81M -383% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $2.62M -$9.12M +$8.83M +49.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-15
Q3 2021 -$6.22M $1.3M +$9.23M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$15.4M $9.18M +$18.7M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$34.2M $1.26M -$5.84M -82.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$28.3M -$18M -$22.8M -474% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-16
Q3 2020 -$5.57M -$7.93M -$20M -166% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $14.4M -$9.54M -$21.5M -180% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $35.9M $7.09M +$1.61M +29.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $34.2M $4.8M -$4.96M -50.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 $39.2M $12M +$3.48M +40.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $35.7M $11.9M +$669K +5.95% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $35.1M $5.48M +$13.3M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-22
Q4 2018 $21.7M $9.76M +$34K +0.35% Oct 1, 2018 Dec 31, 2018 10-K/A 2021-04-26
Q3 2018 $21.7M $8.57M -$1.7M -16.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-28
Q2 2018 $23.4M $11.2M -$6.48M -36.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-26
Q1 2018 $29.9M -$7.83M -$15.8M -198% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 $45.7M $9.73M -$3.01M -23.6% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-06
Q3 2017 $48.7M $10.3M -$3.42M -25% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 $52.2M $17.7M +$4.26M +31.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 $47.9M $8.01M -$2.7M -25.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $50.6M $12.7M -$4.33M -25.3% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $54.9M $13.7M +$554K +4.22% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-27
Q2 2016 $54.4M $13.5M +$1.04M +8.37% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-28
Q1 2016 $53.3M $10.7M +$5.21M +94.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $48.1M $17.1M +$4.98M +41.2% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $43.2M $13.1M +$2.85M +27.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-01
Q2 2015 $40.3M $12.4M -$2.77M -18.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-01
Q1 2015 $43.1M $5.5M -$18.4M -76.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q4 2014 $61.4M $12.1M +$1.66M +15.9% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-24
Q3 2014 $59.8M $10.3M +$2.52M +32.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-03
Q2 2014 $57.3M $15.2M +$5.8M +61.8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 $51.5M $23.9M +$18.9M +376% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-04
Q4 2013 $32.6M $10.4M +$2.64M +33.9% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-10
Q3 2013 $30M $7.77M +$5.04M +185% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $24.9M $9.4M +$3.26M +53.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 $21.7M $5.01M +$1.95M +63.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-05
Q4 2012 $19.7M $7.79M +$2.88M +58.5% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-13
Q3 2012 $16.8M $2.73M -$2.09M -43.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-05
Q2 2012 $18.9M $6.13M +$2.46M +66.8% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $16.5M $3.06M +$2.51M +450% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-06
Q4 2011 $14M $4.92M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-13
Q3 2011 $4.82M +$2.74M +132% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $3.68M +$1.87M +104% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $557K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-07
Q3 2010 $2.08M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $1.8M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.